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Summary
Transcription factors related to the insect sex-determination
gene doublesex (DMRT proteins) control sex determination
and/or sexual differentiation in diverse metazoans and are
implicated in transitions between sex-determining mecha-
nisms during vertebrate evolution [1]. In mice, Dmrt1 is
required for male gonadal differentiation in somatic cells
and germ cells [2–4]. DMRT1 also maintains male gonadal
sex: its loss, even in adults, can trigger sexual cell-fate re-
programming in which male Sertoli cells transdifferentiate
into their female equivalents—granulosa cells—and testic-
ular tissue reorganizes to a more ovarian morphology [5].
Here we use a conditional Dmrt1 transgene to show that
Dmrt1 is not only necessary but also sufficient to specify
male cell identity in the mouse gonad. DMRT1 expression
in the ovary silenced the female sex-maintenance gene
Foxl2 and reprogrammed juvenile and adult granulosa cells
into Sertoli-like cells, triggering formation of structures
resembling male seminiferous tubules. DMRT1 can silence
Foxl2 even in the absence of the testis-determining genes
Sox8 and Sox9.mRNA profiling found that DMRT1 activates
many testicular genes and downregulates ovarian genes
and single-cell RNA sequencing in transdifferentiating cells
identified dynamically expressed candidate mediators of
this process. Strongly upregulated genes were highly en-
riched on chromosome X, consistent with sexually antago-
nistic functions. This study provides an in vivo example of
single-gene reprogramming of cell sexual identity. Our find-
ings suggest a reconsideration of mechanisms involved in
human disorders of sex development (DSDs) and empirically
support evolutionary models in which loss or gain of Dmrt1
function promotes establishment of new vertebrate sex-
determination systems.
Results
Ectopic DMRT1 Induces Formation of Sertoli-like Cells in
the Ovary
Mammalian sex is determined in the fetal gonad by presence
or absence of the Y-linked Sry gene [6]. In genetic males, bipo-
tential precursors become Sertoli cells, whereas in females the
same cells become granulosa cells. These pivotal gonadal
cells trigger a cascade of events leading to body-wide sexual
differentiation and later provide essential support for devel-
oping germ cells. The Sertoli versus granulosa cell-fate deci-
sion is not necessarily permanent: loss of a single transcription*Correspondence: zarko001@umn.edufactor (Dmrt1 in males or Foxl2 in females) can trigger direct
transdifferentiation between the two cell types, even in adults
[5, 7]. Dmrt1 and Foxl2 therefore are essential components of
antagonistic regulatory networks actively maintaining sex in
differentiated cells that retain latent plasticity [8].
Although neither Dmrt1 nor Foxl2 is required for fetal sex
determination in mammals, Dmrt1 orthologs determine sex in
other vertebrates [9–12]. Thus, Dmrt1 can play an instructive
role in determining sexual cell fates. Moreover, Dmrt1 ortho-
logs in such species appear to have undergone mutational
events causing either loss or gain of function, suggesting that
altered Dmrt1 activity helped drive evolutionary transitions
leading to distinct genetic sex-determination systems [1]. To
help evaluate this possibility, we asked whether gain-of-func-
tion in Dmrt1 can determine male fate in the mouse ovary.
To conditionally expressDMRT1,wegeneratedmicewith the
construct CAG-Stop-Dmrt1-Gfp integrated into the Rosa26
locus (Figures 1A, S1A, and S1B). Cre-mediated removal of a
transcriptional stop cassette generatesCAG-Dmrt1-Gfp, which
expresses a bicistronicmRNA encoding DMRT1 and eGFP.We
tested whether CAG-Dmrt1-Gfp can functionally replace the
Dmrt1 gene by activating CAG-Stop-Dmrt1-Gfp while deleting
Dmrt1 with Sf1-Cre, which is expressed in somatic gonadal
cells from embryonic day 10.5 (E10.5) [13]. DMRT1 expression
from Dmrt1-Gfp was comparable to that of the wild-type and
rescued Sertoli differentiation sufficiently to support complete
male spermatogenesis (Figures S1C–S1K).
DMRT1 is expressed in both sexes until about E13.5 and
then becomes testis specific [2, 14–16]. To determine the
effect of ectopic DMRT1 in the ovary we examined adult
mice with CAG-Stop-Dmrt1-Gfp activated by Sf1-Cre. Doubly
transgenic CAG-Stop-Dmrt1-Gfp;Sf1-Cre ovaries had wide-
spread DMRT1 and few FOXL2+ granulosa cells (Figures
1B–1D). DMRT1+ cells often were at the periphery of follicle
remnants (Figure 1D), similar to DMRT1+ Sertoli cells in wild-
type testis tubules (Figure 1B), and most expressed the Sertoli
cell markers SOX9 and GATA1 (Figures 1E–1G). The switch
from FOXL2+ to SOX9+/GATA1+ suggested that granulosa
cells were re-specified as Sertoli-like cells. H&E staining (Fig-
ures 1H–1M) confirmed that transformed cells had typical Ser-
toli morphology, including cell polarization with cytoplasmic
veils (Figure 1M), and often organized in a seminiferous tu-
bule-like arrangement surrounding a central lumen (Figure 1J).
DMRT1 Induces Postnatal Sexual Transdifferention
We next asked whether DMRT1 expression induces male
sex determination or sexual transdifferentiation. Although
Sf1-Cre is active by the time of sex determination (about
E11–E12) [13], transgenic XX animals were born female, with
ovaries containing oocytes in diplotene arrest (Figures S2A–
S2D), suggesting that fetal gonads were functionally female.
By E13.5, CAG-Stop-Dmrt1-Gfp;Sf1-Cre ovaries expressed
ectopic DMRT1 (Figures 2A–2C), but SOX9 was not detectable
until about postnatal day 10 (P10) (Figures 2D–2I). We
conclude that fetal DMRT1 expression causes transdifferen-
tiation rather than primary sex reversal and that fetal granulosa
cells are refractory to SOX9 activation by DMRT1.
In case ectopic DMRT1 was not present early enough to
induce SOX9, we expressed DMRT1 before sex determination
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Figure 1. Ectopic DMRT1 in the Ovary Causes Granulosa Cell to Sertoli-like Cell Differentiation
(A) Schematic diagram of conditional DMRT1 expression transgene CAG-Stop-Dmrt1-Gfp, which is transcribed to express DMRT1 and GFP upon Cre-
mediated deletion of a floxed ‘‘STOP’’ cassette (for additional detail, see Figure S1A).
(B–D) Immunofluorescence (IF) of gonads from 8- to 10-week-old mice showing that activation of CAG-Dmrt1-Gfp in somatic cells of the fetal ovary by Sf1-
Cre activates DMRT1, silencing the ovarian granulosa cell transcription factor FOXL2. Testes normally express DMRT1, but not FOXL2 (B); ovaries express
FOXL2, but not DMRT1 (C); and transgenic ovaries express mainly DMRT1 (D). Dashed boxes indicate areas shown in the higher-magnification insets.
(E–G) IF of adult gonads showing that activation of CAG-Dmrt1-Gfp also activates the Sertoli cell determinant SOX9 and the Sertoli cell differentiation factor
GATA1. Testes normally express both proteins (E), ovaries express neither (F), and transgenic ovaries express both (G). Dashed boxes indicate areas shown
in the higher-magnification insets.
(H–M) H&E-stained sections of adult testes (H), ovaries (I), andCAG-Dmrt1-Gfp expressing ovaries (J) at low and highmagnification (dashed boxes indicate
magnified areas shown in K–M). Ovaries expressing DMRT1 show tubule-like morphology typical of testes, with polarized Sertoli-like cells lining the periph-
ery and extending cytoplasmic veils into a central lumen.
Scale bars represent 100 mm (B–D and H–J), 40 mm (E–G), and 20 mm (K–M). See also Figure S1.
765using Wt1-CreERT2, which is expressed by E9.5 [17]. Earlier
activation did not masculinize the fetal gonad (Figures
S2E–S2H), suggesting that DMRT1 cannot cause primary sex
reversal in the fetal ovary.DMRT1ExpressionReprogramsAdult Granulosa Cells into
Sertoli-like Cells
Adult granulosa cells can transdifferentiate into Sertoli-like
cells when Foxl2 is deleted, and one of the earliest changes
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Figure 2. DMRT1 Expression Triggers Postnatal Granulosa Cell Transdifferentiation
(A–C) Activation of CAG-Dmrt1-Gfp in the fetal gonad. Confocal images of whole mount IF on E13.5 gonads show normal expression of DMRT1 in testis (A)
and ovarian germ cells (B) and activation of CAG-Dmrt1-Gfp in ovarian somatic cells (C) as indicated by cytoplasmic GFP (example is shown in the higher-
magnification inset). Dispersed green cells lacking DMRT1 in wild-type gonads are autofluorescent cells of unknown type.
(D–F) SOX9 expression in the fetal gonad. IF shows that SOX9 is strongly expressed in pre-Sertoli cells of wild-type testes at E13.5 (D) but is not detected in
wild-type fetal ovaries (E) or CAG-Stop-Dmrt1-Gfp;Sf1-Cre transgenic ovaries (F).
(G–I) Postnatal expression of SOX9 and FOXL2. IF shows that wild-type testes at P10 express SOX9 and not FOXL2 (G), wild-type ovaries express FOXL2
and not SOX9 (H), and CAG-Stop-Dmrt1-Gfp;Sf1-Cre transgenic ovaries have cells expressing each protein (I), indicating the onset of transdifferentiation.
(J–O) Transdifferentiation in the adult ovary. Control tamoxifen-injected ovaries from adults carrying CAG-Stop-Dmrt1-Gfp but lacking a Cre transgene do
not express DMRT1 or GFP (J), but ovaries from animals also containing UBC-CreERT2 or Hsd17b1-Cre have cells expressing both proteins (K and L).
Somatic cells from control adult ovaries express FOXL2, but not SOX9 (M), whereas animals withUBC-CreERT2 (N) or Hsd17b1-Cre (O) have cells express-
ing each protein (SOX9 IF in adult oocytes is thought to be a non-specific antibody artifact).
Scale bars represent 40 mm (A–I) and 100 mm (J–O). See also Figure S2.
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767is activation of DMRT1 [7]. We therefore asked whether
activating DMRT1 alone is sufficient to induce transdifferentia-
tion in the adult ovary. DMRT1 activated by ubiquitously ex-
pressed UBC-CreERT2 [18] silenced FOXL2 and resulted in
SOX9+ Sertoli-like cells (Figures 2J, 2K, 2M, and 2N). Expres-
sion of DMRT1 mainly in granulosa cells of growing adult
follicles using Hsd17b1-CreERT2 [19] also caused transdiffer-
entiation, though less efficiently (Figures 2L and 2O). We
conclude that DMRT1 can trigger either juvenile or adult gran-
ulosa cells to transdifferentiate.
DMRT1 Expression Masculinizes the Ovarian
Transcriptome
We used RNA sequencing (RNA-seq) to compare transcrip-
tomes of wild-type adult testes and ovaries to DMRT1-
expressing ovaries (CAG-Stop-Dmrt1-Gfp;Sf1-Cre). DMRT1-
expressing ovaries hadmany differences in mRNA abundance
relative to wild-type ovaries (Figure 3A), with 2,430 mRNAs
overexpressed and 2,078 underexpressed by 2-fold or more
(p < 0.05; DESeq2 Wald test; Table S1, part A). DMRT1-
expressing ovaries had highly elevated expression of the
testicular Leydig cell marker Insl3 (>16-fold), suggesting that
Leydig-like cells also may have been induced [20].
Foxl2 Deletion and DMRT1 Expression Cause Similar
Remodeling of the Ovarian Transcriptome
Foxl2 deletion or Dmrt1 activation triggers transdifferentia-
tion in the ovary, suggesting that repression of DMRT1 is a
primary means by which FOXL2 maintains ovarian cell fates.
To examine this possibility, we compared mRNA profiles
of Foxl2-mutant versus DMRT1-expressing ovaries. We
compared microarray data from Foxl2 conditional mutants
[7] with RNA-seq data from CAG-Stop-Dmrt1-Gfp;Sf1-Cre
ovaries, plotting mRNAs represented in both datasets (Fig-
ure 3B). Ovary- and testis-enriched genes are highlighted in
red and blue, respectively, and constituted the majority of
strongly affected genes. Nearly all genes strongly affected by
loss of Foxl2 were affected by gain of DMRT1 (Figure 3B,
diagonal line), suggesting that ectopic DMRT1 can account
for most of the Foxl2-mutant phenotype. Some mRNAs
were significantly affected in CAG-Stop-Dmrt1-Gfp;Sf1-Cre
ovaries, but not in Foxl2 mutants (Figure 3B, blue and pink
boxes). This difference may reflect the higher expression of
DMRT1 in transgenic ovaries relative to Foxl2-mutant ovaries
(Figure 3B).
One-fifth of highly differentially expressed genes (>32-fold)
in DMRT1-expressing ovaries are X linked (58/288, triangles
in Figure 3B; see also Figures S3A–S3D and Table S1, part
B). As discussed below, this X linkage is consistent with sexual
antagonism.
In spermatogonia, DMRT1 inhibits meiosis by suppressing
retinoic acid (RA) signaling [4].We found significantmisexpres-
sion ofRA-regulated genes [21] in transgenic ovaries (TableS1,
part B), suggesting that DMRT1 also may regulate RA-depen-
dent gene expression in somatic transdifferentiation.
Single Cell Transcriptome Profiling Identifies Candidate
Mediators of Transdifferentiation
Analysis of intact gonads reveals the extent of transdifferentia-
tion. However, transdifferentiation initiates asynchronously, so
whole-gonad transcriptomes provide limited insights into the
dynamics of the process. We therefore turned to single-cell
transcriptomes. We used ovaries from CAG-Stop-Dmrt1-
Gfp;Sf1-Cre females at 17 days, when GFP and DMRT1 arewidely expressed (Figures 3C and 3D) and many cells express
FOXL2, SOX9, or, more rarely, both (Figures 3E–3H). We iso-
lated live GFP+ cells by fluorescence-activated cell sorting
(FACS) and used the Fluidigm C1 system for capture and
cDNA synthesis. We sequenced cDNA libraries from 68 live
cells and used the Monocle dimension reduction algorithm
[22] to place them into a ‘‘pseudotemporal’’ transdifferentia-
tion pathway. This method infers a sequence of gene expres-
sion accounting for the heterogeneity observed between cells.
Ordering was based on expression of 32 abundant mRNAs
selected because of differential expression in the adult testis
versus ovary RNA-seq and presence in at least half of profiled
cells (Table S1, part C). These mRNAs included Serpine2 and
Cst9 (Figure 3I, left). We used a Bayesian probabilistic model
(SCDE [23]) to identify genes differentially expressed between
cells in the first third and last third of pseudotime. Many
mRNAs not used for ordering showed significant variation
from ovary-like to testis-like levels in single cells over pseudo-
time (e.g., Aard, corrected Z score = 1.22; Rhox8, corrected Z
score = 0.9; Figure 3I,middle), suggesting that ordering at least
partially reflects actual temporal change. Single-cell analysis
also detected mRNAs varying in pseudotime that were not de-
tected by analysis of intact DMRT1-expressing ovaries (Mmp2
corrected Z score = 21.0; Col1a1 corrected Z score = 22.4;
Figure 3I, right). The ordering of cells in pseudotime may indi-
cate similarity between transdifferentiation and fetal gonad
development, as 56 of the 777 genes differentially expressed
between the first and last third of pseudotime also exhibit
sexually dimorphic expression in fetal gonads [24] (Table S1,
part C). The mRNAs that differed over transdifferentiation
pseudotime will be important subjects for future investigation.
DMRT1 Can Silence Foxl2 without SOX8 and SOX9
Cell-fate maintenance involves antagonism between DMRT1
and FOXL2. DMRT1 can activate or repress transcription
[25], and chromatin immunoprecipitation experiments suggest
that it directly represses Foxl2 [5]. DMRT1 also activates the
male-determining gene Sox9, which helps maintain male fates
[5, 26]. An important question is whether DMRT1 and FOXL2
antagonize each other directly or by competing to regulate
SOX9. We therefore asked whether DMRT1 can silence Foxl2
in the absence of Sox9.
Adult ovaries with DMRT1 activated and Sox9 deleted using
Sf1-Cre (Figures 4A–4C) had many cells lacking FOXL2
and expressing Sertoli markers SOX8 (Figures 4D–4G) and
GATA1 (Figures 4H–4J), suggesting that DMRT1 can cause
transdifferentiation without Sox9. However, Sox9 is partially
redundant with Sox8 [27, 28], which was elevated in DMRT1-
expressing ovaries (data not shown). We therefore repeated
the experiment in ovaries lacking Sox8 and Sox9. Again,
most DMRT1+ cells had reduced or no FOXL2 (Figures 4K–
4M), indicating that DMRT1 does not require SOX9 or SOX8
to silence FOXL2.
Discussion
We found that ovarian expression of DMRT1 alone can silence
FOXL2 and trigger sexual transdifferentiation. Thus, DMRT1
controls a regulatory network that can sexually reprogram
differentiated cells in vivo. Ectopic DMRT1 activity can ac-
count for virtually all transcriptome changes resulting from
deletion of Foxl2, suggesting that silencing of Dmrt1, directly
or indirectly, is the primary means by which FOXL2 blocks
sexual transdifferentiation.
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Figure 3. DMRT1 Masculinizes the Ovarian Transcriptome
(A) Heatmap comparing mRNA expression in adult wild-type testis and ovary with CAG-Dmrt1-Gfp;Sf1-Cre ovaries. Columns are from RNA-seq of two
gonads (rep1, rep 2) of each genotype. Genes differentially expressed in wild-type ovary and DMRT1-expressing ovary (>4-fold ; p < 0.05; Table S1,
part A) are shown in rows that are sorted based on high expression in the wild-type ovary (top) to high expression in the testis (bottom). Each gene was
normalized to a range of 22 (violet) to +2 (green).
(B) Scatterplot comparing gene expression in adult Foxl2 conditionally mutant ovaries (data from [7]) and CAG-Stop-Dmrt1-Gfp;Sf1-Cre ovaries. Blue
indicates mRNAs with 4-fold or greater expression in wild-type testis versus wild-type ovary, and red indicates those with 4-fold or greater expression
in wild-type ovary versus wild-type testis. Gray indicates mRNAs not differing significantly between testis and ovary. Identities of some of the most strongly
affected mRNAs are indicated. Triangles denote X-linked genes, and blue and pink boxes highlight mRNAs strongly up- or downregulated, respectively, in
CAG-Dmrt1-Gfp-expressing ovaries, but not in Foxl2-mutant ovaries.
(C–H) IF showing that P17CAG-Stop-Dmrt1-Gfp;Sf1-Cre transgenic ovaries have amix of GFP+ cells expressing DMRT1 (C andD), SOX9 (E and F), or FOXL2
(G and H). Scale bars represent 40 mm (C, E, and G) and 20 mm (D, F, and H).
(I)Expression levels (FPKM)of selectmRNAs insinglecells fromP17CAG-Stop-Dmrt1-Gfp;Sf1-Cre transgenicovaries,orderedbypseudotimealong thexaxis.
See also Figure S3 and Table S1.
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Figure 4. DMRT1 Can Silence FOXL2 without SOX8 and SOX9
(A–C) CAG-Stop-Dmrt1-Gfp can silence FOXL2 in Sox9 conditional mutant ovaries. IF shows that SOX9 is expressed in Sertoli cells of wild-type testes (A)
and in Sertoli-like cells of control conditional Sox9/+ DMRT1-expressing ovaries (B). FOXL2 is almost completely silenced in DMRT1-expressing ovaries
conditionally deleted for one (B) or both (C) copies of Sox9 with Sf1-Cre.
(D–G)CAG-Dmrt1-Gfp can activate SOX8 in SOX9-mutant granulosa cells. IF shows that SOX8 is expressed in Sertoli cells in wild-type adult testes (D) and is
not detectable in wild-type adult ovaries (E).CAG-Dmrt1-Gfp can activate SOX8 in ovaries conditionally deleted for one copy (F) or both copies (G) ofSox9 in
somatic cells using Sf1-Cre.
(H–J)CAG-Dmrt1-Gfp can activate the mature Sertoli cell marker GATA1 in Sox9-mutant granulosa cells. IF shows that GATA1 is not expressed in wild-type
adult ovaries (H) but is expressed in ovaries conditionally deleted for one (I) or two (J) copies of Sox9 in somatic cells using Sf1-Cre.
(K–M) DMRT1 silences FOXL2 in granulosa cells lacking both Sox8 and Sox9. IF shows that Sox8;Sox9 double-mutant ovaries have normal FOXL2 expres-
sion and normal morphology and lack DMRT1 (K). Activation of CAG-Dmrt1-Gfp in ovaries heterozygous for Sox8 and Sox9 (L) or homozygous mutant for
both genes in somatic cells (M) can induce DMRT1 expression and silence FOXL2.
Scale bars represent 40 mm (A–D and F–J) and 20 mm (E and K–M).
769Specification of Sertoli or granulosa cells is the crucial first
event in mammalian sex determination and involves activation
of the male-promoting gene Sox9 or, alternatively, a female-
promoting Wnt/b-catenin pathway involving Wnt4 and
Rspo1 [29]. DMRT1 is dispensable for sex determination
in mice [2]. However, XY humans who are hemizygous
for DMRT1 can be born phenotypically female [30–32], so
DMRT1 may play a role in human gonadal sex determination.We found that even in mice, the presence or absence of
DMRT1 can toggle a switch between the Sertoli and granulosa
cell fates. Although this switching occurs postnatally, it never-
theless reveals that DMRT1 can control the choice between
the two cell types that underlie mammalian sex. Human
disorders of sex development (DSDs) have been presumed
to result from incomplete gonadal differentiation, but our
findings suggest that some cases of DSD could involve
770transdifferentiation resulting from mutations causing later
gain or loss of DMRT1.
The ability of ectopic DMRT1 expression to specify Sertoli
cell fates also haspotential significance for understanding evo-
lution of genetic sex-determining mechanisms. In therian
mammals, Y-linked Sry serves to activate Sox9 in the male
gonad, and Sox9 expression can determine sex even without
Sry [28, 33–36]. Other vertebrates lack Sry and control gonadal
sex by different means. DMRT1 regulates sex determination in
an expanding group of non-mammalian vertebrates. In some
species aDMRT1homologacts asadominantY-linkedmascu-
linizing gene (fish) [9], a dose-dependent Z-linked masculin-
izing gene (birds) [11, 12], or a dominant W-linked feminizing
gene (amphibians) [10] (reviewed in [1, 37]). Molecular and
genetic analysis suggests that the acquisition of these genetic
sex-determination mechanisms was tied to dominant gain-
of-function, recessive loss-of-function, or dominant-negative
Dmrt1 alleles, respectively [10–12, 38–40]. These new DMRT1
allelesmay have triggered formation of new sex-determination
mechanisms or merely arisen coincident with them. Regard-
less, the ability of DMRT1 to toggle Sertoli/granulosa cell fate
empirically supports models in which loss- or gain-of-function
mutations in Dmrt1 can elevate it into a sex-determining role
[1, 37]. Suchmutations would help promote themajor changes
between genetic sex-determination mechanisms that are
commonly observed among vertebrates [41, 42].
DMRT1, with other testicular transcription factors (SOX9,
GATA4, NR5A1/SF1, and WT1), can reprogram cultured
induced pluripotent stem cells into Sertoli-like cells in vitro,
but cannot reprogram them on its own [43]. In vivo, by
contrast, DMRT1 can reprogram granulosa cells into Sertoli-
like cells. This difference presumably reflects the greater sim-
ilarity of granulosa cells to Sertoli cells. Indeed, although they
are very different morphologically, both express NR5A1/SF1,
GATA4, and WT1. Also, they arise from a common genital-
ridge precursor cell and thus may be separated by relatively
small epigenetic barriers. Differences between in vivo and
in vitro conditions may be important; however, DMRT1 cannot
reprogram other cells to Sertoli cells in vivo. For example, pre-
granulosa cells and cells of the blastocyst inner cell mass nor-
mally express DMRT1 without adopting Sertoli fates ([2] and
unpublished data). Moreover, broad expression of DMRT1
did not induce SOX9 expression or apparent Sertoli fates in
extragonadal tissues (data not shown).
X-linked genes were highly overrepresented among those
strongly activated by DMRT1 (Figures 3B and S2). X chromo-
somes are predicted to accumulate female-antagonistic
regulators of sexual dimorphism—genes benefitting males
but compromising females [44]. This is because rare male-
advantageous recessive alleles on X get expressed much
more frequently in males than females and thus are likely to
be fixed even if they have a significant female fitness cost.
There is perhaps no more direct sexual antagonism than dur-
ing gonadal development, and our data suggest that the
X-linked targets of DMRT1 include genes with significant roles
in testicular differentiation.
The ability of DMRT1 to induce cell-fate reprogramming pro-
vides a window into transdifferentiation mechanisms, but puz-
zles remain—for examplewhypostnatal but not fetal granulosa
cells canbe reprogrammed.Heremammals differ frombirds, in
which DMRT1 can induce SOX9 and male differentiation at the
normal time of sex determination [12]. Resistance to fetal sex
reversal in mice is also seen in estrogen receptor and Wnt/
b-catenin pathwaymutants [45, 46], and it has been suggestedthat granulosa cells must first undergo a germ-cell-dependent
maturation step [46]. We suggest that resistance to Sox9
induction in fetal pre-granulosa cells may provide a protective
mechanism, as these cells normally express DMRT1 during
sex determination: resisting inappropriate Sox9 activation by
DMRT1 would ensure the fidelity of sex determination during
a critical developmental interval. Such a mechanism might
also contribute to the observed evolutionary stability of the
mammalian sex-determination mechanism.
Experimental Procedures
See the Supplemental Experimental Procedures for details.
Accession Numbers
RNA-seq data are available from Gene Expression Omnibus under acces-
sion number GSE64960.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and one table and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2015.01.034.
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